If I am not mistaking this is the original (closed now) trial:
https://clinicaltrials.gov/ct2/show/NCT01586260
Inclusion Criteria:
- Age: 0-21 years at the time of diagnosis.
- Diagnosis: histologic verification at either the time of original diagnosis or a previous relapse of high risk neuroblastoma.
For me it looks like it is open for everybody…
Also there is an old post from this forum where there is a story about taking DFMO after relapse:
But I would agree with you that there is a lack of official updates from that trial. Especially, when you suppose to pay huge amount just to participate in this trial…